ArticleClinical rheumatology2025

Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort.

Annik Steimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.